Business Context and Reporting Period
Company: Intelligent Bio Solutions Inc. (INBS)
Filing Type: Form 8-K (Current Report)
Date of Report: August 24, 2023
Reporting Period: The filing announces financial results for the three months and full fiscal year ended June 30, 2023. The Company is an emerging growth company incorporated in Delaware.
Key Financial Metrics
The provided text is a cover page and index for the Form 8-K. It references a press release (Exhibit 99.1) containing the actual financial data but does not list specific figures within this document.
- Revenue, Profit, Cash Flow, Margins: Not provided in this text; contained in the referenced press release.
- Debt and Liquidity: Not provided in this text; contained in the referenced press release.
Material Changes
The filing text does not provide specific comparative data or material changes versus prior periods. It serves solely to notify the market of the issuance of the press release regarding the fiscal year ended June 30, 2023.
Guidance, Outlook, and Risks
Management Commentary and Outlook: No specific guidance or outlook is detailed in this filing text. The Company directs readers to the press release for details.
Risks and Contingencies: The filing includes a standard disclaimer stating that the information contained herein and in the accompanying exhibits shall not be incorporated by reference into any other filing unless expressly incorporated by specific reference. It also notes that the information is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 24, 2023) for actual revenue, net income, and cash flow figures.
- Verify the specific details of the fiscal year ended June 30, 2023, as this 8-K only announces the release of those results.
- Confirm the Company's status as an emerging growth company and its implications for financial reporting standards.